Drugs / Listerine Zero
last change Sep 2022 re-read 3 minutes ago

Listerine Zero

Developed for
COVID-19
Investigated by
Rowpar Pharmaceuticals, Inc. · University of California, San Francisco

Trials 1

20222023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT04409873 Mar 2021 → Sep 2022 COVID-19, disorder of pharynx University of California, San Francisco Terminated Missed primary Stop: Enrollment

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Listerine Zero ClinicalTrials.gov intervention name — accepted as the source's own label NCT04409873 ↗